Adana Baskent Hospital

Adana 34920

0 studies enrolling now · 3 studies all time

What they study most

Advanced or Metastatic Non-small Cell Lung Cancer, Endometrial Cancer, Multiple Sclerosis, Relapsing-Remitting

Studies at this site

• A Study of Lazertinib With Subcutaneous Amivantamab Compared With Intravenous Amivantamab in Participants With Epidermal Growth Factor Receptor (EGFR)-Mutated Advanced or Metastatic Non-small Cell Lung Cancer — Running, not enrolling
• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
• Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis — Running, not enrolling